While U.S. regulators are pushing for more transparency and audit quality of Chinese firms listing on U.S. stock exchanges, some plaintiffs firms still see high risks for investors.
A recent executive order issued by U.S. President Joe Biden heightened the level of scrutiny of inbound deals in certain sensitive industries. And now the U.S. is weighing legislation that calls for a "reverse CFIUS," which will add government scrutiny to outbound transactions.
As the relationship between the U.S. and China has deteriorated, an increasing number of Chinese companies are ending their U.S.-based operations. Derek Liu, Rod Hunter and Howard Wu of Baker McKenzie set out some guidance for those heading down that path
CAC publishes guidelines for data export security assessment; Tencent Huanhe stops selling NFTs due to regulatory challenges; Proposal to enhance protection of wildlife under review
Lawyers also say U.S.-China trade tensions could be further damaged by "reverse CFIUS," a proposed law under which the U.S. government could prohibit investments into China it deems a threat to certain domestic capabilities.
PCAOB and Beijing reach audit agreement to prevent mass delisting; U.S.-China merger abandoned following U.S. antitrust investigation; new compliance rules for wealth management companies
CFIUS publishes data from 2021; Autonomous vehicles can be driven in simple and controlled conditions; Trust firms' loans to real estate sector audited
The U.S. adds Alibaba to delisting list, citing audit non-compliance; Integration of Shenzhen and Swiss bourses; Six ESG-linked indices launched in Shenzhen
